Runze Wen | Cardiac Imaging | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Runze Wen | Cardiac Imaging | Best Researcher Award

The First Affiliated Hospital of University of Science and Technology | China

Dr. Runze Wen is an emerging scholar in the field of Cardiac Nuclear Medicine, currently pursuing his doctoral degree at the University of Science and Technology of China. His research focuses on advancing nuclear imaging techniques for cardiovascular diagnostics, with a strong emphasis on enhancing the precision and clinical applicability of cardiac assessments. Despite being at an early stage in his academic career, Dr. Wen has already demonstrated remarkable productivity and impact within the scientific community, with 3 published documents, 13 citations across 13 referencing works, and an h index of 3, a clear indication of the relevance and influence of his research. His investigations often integrate nuclear imaging modalities with innovative diagnostic approaches to improve the understanding of coronary microvascular dysfunction and other complex cardiac conditions. In addition to his academic achievements, Dr. Wen is a Fellow in Training (FIT) member of the American College of Cardiology (ACC), reflecting his commitment to professional development and international collaboration within the cardiology field. His ability to bridge advanced imaging science with clinical cardiology has earned him recognition as a promising young researcher dedicated to transforming cardiovascular diagnostics. Through his ongoing research and active engagement in academic circles, Dr. Runze Wen continues to contribute meaningfully to the future of nuclear cardiology, aiming to enhance patient care through evidence based innovation and interdisciplinary research excellence.

Profiles: Scopus | Orcid

Featured Publications

Wen, R., Xie, Q., Pan, B., Ni, M., Zhu, X., Meng, X., Wei, Z., Wu, X., Li, D., & Wang, X. (2025). Simultaneous 13N-ammonia and gadolinium perfusion using integrated PET–MRI: Diagnostic accuracy in coronary microvascular dysfunction. Frontiers in Medicine

Wen, R., Zhao, M., Chen, C., Yang, Y., & Zhang, B. (2023). A novel nomogram integrated with preablation stimulated thyroglobulin and thyroglobulin/thyroid-stimulating hormone ratio to predict the therapeutic response of intermediate- and high-risk differentiated thyroid cancer patients: A bi-center retrospective study.

Tao Chen | Cardiovascular Mortality | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Tao Chen | Cardiovascular Mortality | Best Researcher Award

Fujian Medical University | China 

Tao Chen is a distinguished medical professional and researcher in the field of endocrinology and metabolism, currently serving as an Associate Chief Physician at the Affiliated Longyan First Hospital of Fujian Medical University and as a postgraduate tutor at Fujian Medical University. With extensive clinical and academic experience, he has played a vital role in medical education, scientific research, and the advancement of endocrine medicine. His primary research interests encompass diabetes, insulin resistance, metabolic disorders, osteoporosis, and the role of vitamin D in neuropathy. Tao Chen has published five scholarly papers focusing on topics such as glucose regulation, serum irisin levels and their relationship with insulin sensitivity, the effects of exercise on metabolic indicators, and vitamin D3-related complications in type 2 diabetes. His publications have collectively received 25 citations across 5 documents, and he holds an h-index of 3, reflecting his consistent contribution to clinical and academic research. Beyond research, he is actively involved in multiple professional organizations, serving as a council and committee member in various endocrinology and diabetes societies. He is also the Vice Chairman of the Osteoporosis and Bone Mineral Salt Disease Branch of the Longyan Medical Association and serves as a food and drug safety expert for the Longyan Municipal People’s Government. Through his ongoing leadership, research, and mentorship, Tao Chen continues to make meaningful contributions to endocrinology and medical science.

Profiles: Scopus | Orcid

Featured Publications

Lai, X., & Chen, T. (2024). Association of serum uric acid to high-density lipoprotein cholesterol ratio with all-cause and cardiovascular mortality in patients with diabetes or prediabetes: A prospective cohort study. Frontiers in Endocrinology.

Lai, X., & Chen, T. (2024). Association between the triglyceride–glucose index and serum soluble Klotho in middle-aged and older adults from NHANES 2007–2016. Scientific Reports.

Chen, T., Xing, X., Huang, L., Tu, M., Lai, X., Wen, S., Cai, J., Lin, S., Zheng, Y., Lin, Y., et al. (2023). Efficacy and safety of high-dose intramuscular vitamin D₂ injection in type 2 diabetes mellitus with distal symmetric polyneuropathy combined with vitamin D insufficiency: Study protocol for a multicenter, randomized, double-blinded, and placebo-controlled trial. Frontiers in Endocrinology.

Chen, T. (2022). Type 2 diabetes mellitus complicated with atherosclerotic cardiovascular disease patient treated with semaglutide: A case report. Chinese Journal of Diabetes.

Yuan-Biao Qiao | Cardiovascular Pharmacology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Yuan-Biao Qiao | Cardiovascular Pharmacology | Best Researcher Award

Lakshmanan Loganathan | Pharmacogenomics | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Lakshmanan Loganathan | Pharmacogenomics | Best Researcher Award 

Dr. Lakshmanan Loganathan, Micro Health Laboratories, India

Dr. Lakshmanan Loganathan is a Scientist ‘C’ and Scientific Coordinator at Micro Health Laboratories, India, with over nine years of research experience and three years in the diagnostics field. Specializing in computational biology, drug design, microbial genomics, medical genetics, and pharmacogenomics, he has successfully led numerous research projects and developed innovative methodologies. Dr. Loganathan has expertise in structure-based and ligand-based drug design, molecular dynamics, RT-PCR, and SNP studies. With a strong background in computational skills, project management, and scientific communication, he is dedicated to advancing human health through cutting-edge research.

Profile:

Scopus Profile 

Orcid Profile

Google Scholar

 

Education Qualification:

 

Dr. Lakshmanan Loganathan holds a Ph.D. in Bioinformatics from Alagappa University, Karaikudi (2022), where he conducted a highly commendable thesis on RAS and CYP gene polymorphisms in anti-hypertensive treatment. He also earned a PG Diploma in Structural Pharmacogenomics (2015) with the university’s top rank and an M.Sc. in Bioinformatics (2014), both from Alagappa University, achieving high commendations for his innovative research in molecular docking and genomics. Additionally, he holds a B.Sc. in Microbiology from Yadava Arts & Science, Madurai (2012).

Professional Experiences:

Dr. Lakshmanan Loganathan is a Scientist ‘C’ and Scientific Coordinator at Micro Health Laboratories in India, where he has been instrumental in designing and implementing innovative experiments to develop cost-effective diagnostic tests since November 2022. His career includes extensive experience as a Research Scholar at Alagappa University, where he published multiple academic papers and contributed to collaborative research projects. Previously, he held positions such as Lab Manager and Research Associate at Rainbow Children’s Medicare, where he assisted in developing a molecular genetics laboratory and managed the NABL accreditation process. His role as Manager of Lab Operations at SciGene Diagnostics involved overseeing various departments and establishing effective communication with key stakeholders. With a strong background in research, diagnostics, and technical documentation, Dr. Loganathan is dedicated to advancing medical science through innovative methodologies and quality assurance processes.

 Academic Merit & Awards :

Dr. Lakshmanan Loganathan has made significant contributions to the field of bioinformatics, receiving numerous accolades throughout his academic and professional journey. He participated in the UGC-Resource Networking Summer Training Program at Jawaharlal Nehru University in 2013 and was honored with a certificate of appreciation from the Prime Minister of India for his involvement in the Republic Day Parade in 2014. In recognition of his outstanding academic performance during his M.Sc. at Alagappa University, he was named the “Meritorious Student of the Year” for 2013 and received several scholarships, including the PMT & VOC merit scholarship. During his Ph.D. tenure from 2015 to 2020, he was awarded fellowships from DBT, MHRD, and RUSA. Dr. Loganathan also received the special prize for best poster presentation at the ICCIPS-2019 conference and was recognized as the “INTERNATIONAL BEST RESEARCHER” in bioinformatics at the IISTAC-2022 congress.

Thesis work:

Dr. Lakshmanan Loganathan has a robust academic background in bioinformatics, with a focus on microbiology and pharmacogenomics. He completed a six-month post-M.Sc. dissertation on “Identification of Vibrio harveyi through 16s rRNA sequencing” under the guidance of Dr. P. Srinivasan at Alagappa University. Additionally, he undertook a six-month postgraduate diploma project on “Identification of potent inhibitors against NS3 helicase protein of Zika virus,” supervised by Dr. M. Karthikeyan. Dr. Loganathan’s Ph.D. thesis, titled “Role of RAS and CYP Gene Polymorphisms in Anti-Hypertensive Treatment,” also under the supervision of Dr. Karthikeyan, was highly commended for its contributions to pharmacogenomics and computational studies.

Top Notable Publications:

Renin and CYP P450 gene variations significantly associated with essential hypertension: A prospective pharmacogenomics study

Authors: Loganathan, L., Carlus, S.J., Muthusamy, K.

Year: 2024

Journal: Gene Reports

Volume: 37

Article Number: 102023

Citations: 0

HTNpedia: A Knowledge Base for Hypertension Research

Authors: Loganathan, L., Jeyaraman, J., Muthusamy, K.

Year: 2024

Journal: Combinatorial Chemistry and High Throughput Screening

Volume: 27(5)

Pages: 745–753

Citations: 0

In silico prediction, molecular modeling, and dynamics studies on the targeted next-generation sequencing identified genes underlying congenital heart disease in Down syndrome patients

Authors: Carlus, F.H., Sujatha, L.B., Kumar, A.G., Muthusamy, K., Carlus, S.J., et al.

Year: 2023

Journal: Annals of Pediatric Cardiology

Volume: 16(4)

Pages: 266–275

Citations: 0

Theoretical investigation on known renin inhibitors and generation of ligand-based pharmacophore models for hypertension treatment

Authors: Loganathan, L., Sankar, J., Rajendran, K., Muthusamy, K.

Year: 2023

Journal: Journal of Biomolecular Structure and Dynamics

Citations: 1

Targeting renin receptor for the inhibition of renin angiotensin aldosterone system: An alternative approach through in silico drug discovery

Authors: Loganathan, L., Briget Kuriakose, B., Lobelle Sampayan, E., Muthusamy, K.

Year: 2022

Journal: Computational and Theoretical Chemistry

Volume: 1208

Article Number: 113541

Citations: 1

An in silico analysis of the impact of POLE mutations on cladribine docking

Authors: Loganathan, L., Al-Haidose, A., Ganesh Kumar, A., Carlus, S.J., Abdallah, A.M.

Year: 2022

Journal: European Review for Medical and Pharmacological Sciences

Volume: 26(20)

Pages: 7580–7593

Citations: 3

Mechanistic insights on nsSNPs on binding site of renin and cytochrome P450 proteins: A computational perceptual study for pharmacogenomics evaluation

Authors: Loganathan, L., Kuriakose, B.B., Mushfiq, S., Muthusamy, K.

Year: 2021

Journal: Journal of Cellular Biochemistry

Volume: 122(10)

Pages: 1460–1474

Citations: 17

In silico drug designing for the identification of promising antagonist hit molecules against bradykinin receptor

Authors: Selvaraj, M., Loganathan, L., Kumar Thirumalaisamy, P., Lobelle Sampayan, E., Muthusamy, K.

Year: 2021

Journal: Computational and Theoretical Chemistry

Volume: 1202

Article Number: 113334

Citations: 0

Virtual screening assisted discovery of novel natural products to inhibit the catalytic mechanism of Mycobacterium tuberculosis InhA

Authors: Jayaraman, M., Loganathan, L., Muthusamy, K., Ramadas, K.

Year: 2021

Journal: Journal of Molecular Liquids

Volume: 335

Article Number: 116204

Citations: 21

Computational study on cross-talking cancer signalling mechanism of ring finger protein 146, AXIN and Tankyrase protein complex

Authors: Loganathan, L., Natarajan, K., Muthusamy, K.

Year: 2020

Journal: Journal of Biomolecular Structure and Dynamics

Volume: 38(17)

Pages: 5173–5185

Citations: 7